| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |